Germany, France and Italy said on Monday (15 March) they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization (WHO) said there was no proven link and people should not panic, write Thomas Escritt, Stephanie Nebehay, Panarat Thepgumpanat in BANGKOK, Andreas Rinke, Paul Carrel and Douglas Busvine in BERLIN, Angelo Amante in ROME, Christian Lowe in PARIS, Toby Sterling in AMSTERDAM, Jacob Gronholt-Pedersen in COPENHAGEN, Kate Kelland in LONDON, Emilio Parodi in MILAN, Nathan Allen in MADRID, Emma Farge in GENEVA and Stanley Widianto in JAKARTA.
Still, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.
Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.
Spain will stop using the vaccine for at least 15 days, Cadena Ser radio reported, citing unnamed sources.
The top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.
“We do not want people to panic,” Soumya Swaminathan said on a virtual media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.
WHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.
The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.
Germany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.
German Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.
“This is a professional decision, not a political one,” Spahn said, adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.
France said it was suspending the vaccine’s use pending an assessment by EMA.
“The decision taken, in conformity also with our European policy, is to suspend, out of precaution, vaccination with the AZ shot, hoping that we can resume quickly if the EMA’s guidance allows,” French President Emmanuel Macron said.
Italy said its halt was a “precautionary and temporary measure” pending EMA’s ruling.
“The EMA will meet soon to clarify any doubts so that the AstraZeneca vaccine can be resumed safely in the vaccination campaign as soon as possible,” said Gianni Rezza, Director General of Prevention at Italy’s Ministry of Health.
Austria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.
The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.
“This does not necessarily mean these events are linked to COVID-19 vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place,” he told the media briefing.
The United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.
The EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.
Michael Head, a senior research fellow in global health at the University of Southampton, said the decisions by France, Germany and others looked baffling.
“The data we have suggests that numbers of adverse events related to blood clots are the same (and possibly, in fact lower) in vaccinated groups compared to unvaccinated populations,” he said, adding that halting a vaccination programme had consequences.
“This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned. There are no signs yet of any data that really justify these decisions.”
A senior German infectious diseases physician, however, said the background incidence of 2-5 thromboses per million per year was significantly lower than the number of 7 out of 1.6 million vaccinated people cited by Germany’s health ministry.
“This should be the reason to suspend the vaccination in Germany until all cases, including suspected cases in Germany and Europe, have been completely cleared up,” said Clemens Wendtner, head of the special unit for highly contagious life threatening infections at the Schwabing Clinic in Munich.
AstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019, and is set to be the mainstay of vaccination programmes in much of the developing world.
Thailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday, but Indonesia said it would wait for the WHO to report.
The WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.
The EMA has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.
But the handful of reported side-effects in Europe have upset vaccination programmes already stumbling over slow rollouts and vaccine scepticism in some countries.
The Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca shot, hours after putting its vaccination programme on hold following reports of potential side-effects in other countries.
Recent information indicates “a very special, rarely occurring form of thrombosis, of which some cases appear to have occurred shortly after vaccination. This is of course suspicious and should be investigated,” said Anke Huckriede, vaccinology professor at the University of Groningen in the Netherlands.
Denmark reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.
One of the three health workers hospitalised in Norway after receiving the AstraZeneca shot had died, health authorities said on Monday, but there was no evidence the vaccine was the cause.
AstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.
Long-awaited results from AstraZeneca’s 30,000-person U.S. vaccine trial are now being reviewed by independent monitors to determine whether the shot is safe and effective, a top U.S. official said on Monday.
Bulgaria to hold fresh general election on 11 July - president
Bulgaria will hold a snap parliamentary election on 11 July, after a third and final attempt to form a government following 4 April polls that led to a fragmented parliament failed, President Rumen Radev (pictured) said today (5 May), writes Tsvetelia Tsolova.
Outgoing Prime Minister Boyko Borissov's centre-right GERB, which has dominated Bulgarian politics over the last decade, again emerged as the largest party after last month's election but it lost seats amid widespread public anger over corruption in the European Union's poorest member state.
With Borissov short of a majority and unable to forge a new coalition, the president had asked a new anti-elite party led by TV host Slavi Trifonov to do so but it also failed, as did the third largest party in the new parliament, the Socialists.
"Bulgaria needs a strong-willed political alternative, which the current parliament failed to produce," Radev said after the Socialist Party returned the mandate to form a government.
The stalemate left Radev, a harsh critic of Borissov's failure to crack down on graft, with no alternative but to appoint an interim technocrat administration and call another snap election within two months.
The prolonged political uncertainty is unlikely to undermine Bulgaria's prudent fiscal policies and its commitment to adopting the euro currency due to a broad political consensus in Sofia on these issues, ratings agency Fitch said on Tuesday.
Fitch, which rates Bulgaria at investment BBB grade with a positive outlook, said that a protracted political deadlock could delay reforms, needed for the efficient tapping of the EU's €750 billion coronavirus Recovery Fund
Radev linked the setting of the date for the new election with the appointment of a new central electoral commission that is expected to be finalised on 11 May.
"Next week I will dissolve the parliament and appoint an interim government. In this situation, the election is expected to be held on 11 July," Radev said in a live broadcast.
Radev said he plans to appoint experts as interim ministers, including members of the Socialist Party, which has already said it would back him in his own re-election bid in a presidential vote due in the autumn.
The caretaker government will face a challenging agenda of managing a health and economic crisis triggered by the coronavirus pandemic within a tight budget it cannot amend and of ensuring a fair election.
A recent opinion poll showed GERB remains the most popular party, but its key rival, Trifonov's There Is Such a People, is a close second, raising the prospect of continued fragmentation in which the politicians will struggle to form a stable coalition government.
Bulgaria faces fresh elections as Socialists refuse to form a government
Bulgaria will head to the polls in July after the Socialists on Saturday (1 May) became the third political party to refuse to lead a government following last month's parliamentary election.
The Socialists, who lost almost half of their seats in the April 4 election, said it would be impossible to build a working majority in a fragmented parliament and would return the mandate immediately after the president hands it to them on May 5.
President Rumen Radev faces having to dissolve parliament, appoint an interim administration and call snap polls within two months - most likely on July 11.
Prolonged political uncertainty could hamper the European Union's poorest member state's ability to restart its pandemic battered economy and effectively tap the EU's 750 billion euro ($896 billion) coronavirus Recovery Fund.
The Socialists' decision comes after both the centre-right GERB party of outgoing, three-time Prime Minister Boyko Borissov and the new anti-establishment ITN party, led by TV host and singer Slavi Trifonov, both gave up on attempts to form a government.
Popular anger against widespread corruption after almost a decade of Borissov's governance has boosted support for the anti-elite ITN party and two smaller anti-graft groupings, though the three together lack a majority in the chamber.
The Socialists, who have campaigned to unseat Borissov's GERB, said the three new parties have refused to enter into alliance with them.
"The three new parties in the parliament showed political immaturity, they could not overcome their ego," Socialist leader Kornelia Ninova told reporters after a party meeting.
"In this situation, despite our will for a change a government led by us, even a temporary one, is impossible."
Daniel Mitov proposed as Bulgaria’s next prime minister
Bulgarian media is reporting today (15 April) that the ruling GERB party is proposing Daniel Mitov (pictured) to be Bulgaria’s next prime minister. Boyko Borissov, prime minister and leader of GERB party that won the largest share of votes in the April 4 parliamentary elections, said on April 14 at a meeting of the party's parliamentary group that they were also proposing Tsveta Karayancheva as Speaker of the National Assembly, and Desislava Atanasova as chair of the parliamentary group. Borissov called on all parties to take a responsible approach to the mandates for forming a government in the wake of the pandemic and financial and economic crisis.
Daniel Mitov is a former minister of foreign affairs in the cabinet, known as "Borissov 2". Mitov's career began in the Democrats for a Strong Bulgaria party, continued in the Bulgaria of the Citizens Movement, then he was foreign minister in the caretaker government with Prime Minister Georgi Bliznashki and in the second government of Boyko Borissov. Mitov is already a member of GERB and elected MP from their list of candidates.
On 14 April, the cabinet Borisov 3 held its final regular weekly meeting.
Borissov said that GERB would act responsibly in dealing with the mandate that will be assigned to them for forming a new cabinet.
The government, according to the Constitution, must resign before the newly elected Parliament, which meets for its first sitting tomorrow, April 15. Until a new cabinet is announced, the old one continues to perform its functions, but in resignation. It remains to be seen if a new government will be formed after the cycle of mandates, or if a caretaker government will be appointed.
Environment5 days ago
EU Cohesion policy: €84 million for urban wastewater treatment plant in Marathon, Greece
Agriculture5 days ago
Commission extends flexibilities of Common Agricultural Policy checks for 2021
coronavirus5 days ago
Education: Commission launches expert group to step up investment in education in times of COVID-19
COVID-194 days ago
EU launches new strategy to develop therapeutic treatments for COVID-19
Environment5 days ago
EU sets plan to promote rapid green transition of key industries
UK4 days ago
European Commission calls for calm over Jersey fishing dispute
EU5 days ago
European Globalization Adjustment Fund: helping redundant workers
Defence4 days ago
Defence: Is the EU creating a European army?